Tuosheng Pharmaceuticals is based in Hefei, China. It has raised $40M in total funding. Latest round: Early Stage VC.
Tuosheng Pharmaceuticals funding overview
Tuosheng Pharmaceuticals is based in Hefei, China. Tuosheng Pharmaceuticals has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an Early Stage VC announced in February 2026. The round record for Tuosheng Pharmaceuticals runs through 2026; nothing later has been disclosed. Investors on record include Betta Pharmaceuticals, Hangzhou Tigermed Consulting Company, Ningbo Hongning Hengtai Investment Management, Shanghai Songjiang State-owned Assets Investment, Shenzhen Jiadaogu Investment Management. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Tuosheng Pharmaceuticals funding
How much has Tuosheng Pharmaceuticals raised?
Tuosheng Pharmaceuticals has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Tuosheng Pharmaceuticals?
Betta Pharmaceuticals, Hangzhou Tigermed Consulting Company, Ningbo Hongning Hengtai Investment Management, Shanghai Songjiang State-owned Assets Investment, Shenzhen Jiadaogu Investment Management are named among the investors backing Tuosheng Pharmaceuticals.
What was the latest Tuosheng Pharmaceuticals funding round?
The most recent disclosed round is an Early Stage VC, announced in February 2026.
Where is Tuosheng Pharmaceuticals based?
Tuosheng Pharmaceuticals is based in Hefei, China.
When did Tuosheng Pharmaceuticals last raise?
The last disclosed Tuosheng Pharmaceuticals round closed in February 2026 at Early Stage VC.
Tuosheng Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hefei below to benchmark round size and investor mix.
Companies related to Tuosheng Pharmaceuticals (13)
